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Background
Bladder health is an important component of an
individual’s overall health. Recently, experts from a
variety of disciplines convened to develop a bladder
health initiative. This expert panel was convened and
sponsored by Pﬁzer Inc and was composed of the
seven authors and three additional individuals
acknowledged at the end of this article. This panel
determined that a consensus statement was needed
to raise awareness of the importance of bladder
health among the general public, clinicians, policy
makers and public health ofﬁcials. In this consensus
statement, a deﬁnition for ‘bladder health’ and areas
for intervention are proposed. The goal of this state-
ment is to minimise the negative impact of poor
bladder health on individuals who are directly or
indirectly affected, such as patients, family members,
healthcare professionals, educators, employers and
payors, and to stimulate efforts that may lead to pre-
vention of bladder conditions that affect overall well-
being.
An unhealthy bladder may be characterised by the
presence of one or more symptoms or disease such
as increased voiding frequency or cancer. A number
of conditions may cause lower urinary tract symp-
toms (LUTS), including but not limited to overactive
bladder (OAB), bladder outlet obstruction (BOO),
bladder pain syndrome⁄interstitial cystitis (BPS⁄IC),
urinary tract infection (UTI) and bladder cancers
(1). LUTS can be divided into three categories: stor-
age, voiding and postmicturition (Table 1) (1). Stor-
age symptoms include urinary incontinence (UI,
including stress, urgency or mixed incontinence),
increased daytime voiding frequency, nocturia and
urgency. Voiding symptoms include hesitancy, slow
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SUMMARY
A panel of experts in urology, urogynecology, nursing, and behavioral therapy con-
vened in 2010 to discuss the importance of a healthy bladder on overall health.
They determined that a consensus statement was necessary to raise awareness
among the general public, healthcare providers, payors, and policymakers, with the
goals of minimizing the impact of poor bladder health and stimulating primary pre-
vention of bladder conditions. In this statement, ‘healthy’ bladder function is
described, as well as internal and external factors that inﬂuence bladder health. It
is suggested that primary prevention strategies should be aimed at providing edu-
cation regarding normal lower urinary tract structures and functioning to the pub-
lic, including patients and healthcare providers. This education may promote the
achievement of optimal bladder health by increasing healthy bladder habits and
behaviors, awareness of risk factors, healthcare seeking, and clinician engagement
and reducing stigma and other barriers to treatment. Promoting optimal bladder
health may reduce the personal, societal and economic impact of bladder condi-
tions, including anxiety and depression and costs associated with conditions or dis-
eases and their treatment. While adopting healthy bladder habits and behaviors
and behaviors may improve or maintain bladder health, it is important to recognize
that certain symptoms may indicate the presence of conditions that require medical
attention; many bladder conditions are treatable with a range of options for most
bladder conditions. Lastly, the authors propose clinical directives based on persua-
sive and convergent research to improve and maintain bladder health. The authors
hope that this statement will lead to promotion and achievement of optimal blad-
der health, which may improve overall health and help minimize the effects of
bladder conditions on the public, healthcare professionals, educators, employers,
and payors. The advisors are in consensus regarding the recommendations for
improving and maintaining bladder health presented herein.
What’s known
An unhealthy bladder may be evidenced by the
presence of symptoms or disease. Bladder
conditions affect a large proportion of the world
population, and are associated with substantial
economic and humanistic costs to society.
What’s new
A panel of experts in urology, urogynecology,
nursing, and behavioral therapy determined that a
consensus statement was necessary to raise
awareness of the importance of a healthy bladder
on overall health among the general public,
healthcare providers, payors, and policymakers. It is
suggested that primary prevention strategies should
be aimed at providing education regarding normal
lower urinary tract structures and functioning.
Clinical directives are proposed to improve and
maintain bladder health.
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1026 doi: 10.1111/j.1742-1241.2011.02763.xstream, straining and spraying. Postmicturition
symptoms include feeling of incomplete emptying
and postmicturition leakage. BPS⁄IC is deﬁned as an
unpleasant sensation (pain, pressure discomfort) per-
ceived to be related to the urinary bladder, associated
with LUTS of more than 6 weeks duration, in the
absence of infection or other identiﬁable causes (2)
Prevalence of bladder conditions
Bladder conditions affect a large proportion of the
world population. It has been estimated that in
2008 over 45% of the world population aged
‡ 20 years (1.9 billion people) were affected by
LUTS (3). Approximately 8.2% (348 million) of the
2008 world population were estimated to be
affected by UI, including 3.2% with stress UI, 1.2%
with urgency UI, 1.3% with mixed UI and 2.5%
with UI without symptoms of stress or urgency UI
(3). The prevalence of OAB, deﬁned by urgency,
with or without urgency UI, usually with increased
daytime frequency and nocturia, is approximately
12% (men, 11%; women, 13%) in Europe and
North America (4), with almost 11% of the world
population (455 million people) affected by OAB
(3). The worldwide prevalence of LUTS suggestive
of BOO in 2008 was estimated to be 21.5% (917
million people) (3). The prevalence of BPS⁄IC is
difﬁcult to determine because of the lack of vali-
dated questionnaires for use in epidemiological
studies and misunderstanding of the deﬁnition of
IC (5). However, one study conducted in the Uni-
ted States reported that the prevalence of BPS⁄IC
symptoms among adults aged ‡ 30 years ranged
from 0.83% to 2.71% in women and 0.25% to
1.22% in men (6), whereas another US study esti-
mated that the prevalence among women aged
‡ 18 years was approximately 3–6% (7). UTI is
among the most common reasons for treatment in
adult primary care clinical practice (8). It is the
most common infectious disease among women
worldwide (excluding intestinal disease) and is asso-
ciated with a high recurrence rate (9). Globally,
bladder cancer is the 7th most common cancer in
men and the 17th most common in women. How-
ever, the prevalence of bladder cancer varies among
countries, with the highest prevalence in Western
countries and lowest prevalence in Asian countries
(10–12). The risk of bladder cancer and associated
mortality increases with age (13).
Financial and personal burden of bladder
conditions
Bladder conditions are associated with substantial
costs to society both economically and socially. The
mean cost of routine care (incontinence pads, laun-
dry, etc.) per person among women with UI in 2005
were estimated at approximately $492 ± 898 US dol-
lars per year and increased with UI severity (14). In
a study of women with stress UI, mean annual cost
of incontinence management in 2007 was approxi-
mately $750, including the cost of pads and dry
cleaning (15). Urinary incontinence is also associated
with a high risk of nursing home placement, which
bears signiﬁcant ﬁnancial and emotional burdens
(16,17). The total (direct and indirect) costs associ-
ated with OAB in 2007 were estimated to be $65.9
billion in the US alone (18). Costs for BPS⁄IC are
also substantial (19); annual per person costs in the
USA in 2005 were estimated to range from $3631
(Medicare rates) to $7043 (non-Medicare rates) (20).
There is also considerable annual cost associated with
UTI, which was estimated to be approximately $1.6
billion in 2003 (21,22). Bladder cancer is associated
with the highest lifetime cost per patient of any can-
cer, with the total annual cost estimated at $3.4 bil-
lion in the USA in 2002 (23).
In addition to the economic burden, bladder
conditions negatively impact many aspects of the
health-related quality of life (HRQL) (24). This is
important, as the World Health Organization recog-
nises that ‘health is not only the absence of inﬁrmity
and disease but also a state of physical, mental and
social well-being’ (25). Emotional well-being, a com-
ponent of overall health, is known to be affected by
bladder health. For example, LUTS are associated
with increased anxiety and depression, decreased
physical activity, reduced work productivity (absen-
teeism) and impaired sexual function (26,27). OAB
and UI are bothersome and both can be incapacitat-
ing conditions (26,28,29). UI is associated with
depression in men and women, with prevalence of
depression increasing with severity of incontinence
(30–33). In men, UI is signiﬁcantly associated with
major depression (per 10-year increase, OR 2.7; 95%
CI 1.6, 4.0) (30); similarly, depression is a predictor
for urgency UI in women (32,34). UI may be associ-
ated with high-impact physical activity in young
women, as high rates of UI have been reported in
female athletes (35–38), dancers (38), ﬁtness instruc-
Table 1 Classiﬁcations of LUTS
Storage Voiding Postmicturition
Urgency Slow stream Postmicturition dribble
Frequency Splitting⁄spraying Incomplete emptying
Nocturia Intermittent stream
Incontinence Hesitancy
Straining
Terminal dribble
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Academy (40). Among older men and women, OAB
symptoms are associated with increased risk of falls
and fractures, UTIs and perineal skin disorders
including incontinence-associated dermatitis (41).
BPS⁄IC is associated with lower HRQL, poor sleep
and increased anxiety, stress and depression com-
pared with controls (42).
The impact of UI on physical activity has far-
reaching implications for prevention of cardiovascu-
lar disease, diabetes and other chronic illness. As UI
severity increases, it imposes an increasingly greater
barrier to physical exercise (43). Several types of
bladder conditions, including OAB, UI, stress UI,
LUTS and BPS⁄IC are associated with lost work pro-
ductivity (26,27,44). Bladder cancer and its treat-
ments also profoundly reduce HRQL in survivors
and their families (45–48). The impact of poor blad-
der health on society is not fully appreciated by most
healthcare professionals or the general public, includ-
ing the affected individuals, which likely account at
least in part for the underdiagnosis and undertreat-
ment of many bladder disorders (49). We believe
that by deﬁning and promoting ‘bladder health,’
healthcare providers can improve the overall health
of those directly and indirectly affected.
Developing a bladder health consensus
statement
The International Consultation on Incontinence
(ICI) has provided guidance on promoting conti-
nence, including raising awareness among sufferers,
educating healthcare providers and primary preven-
tion of UI, as well as pelvic organ prolapse and faecal
incontinence (50). Moreover, it has been demon-
strated that bladder health programmes, such as
community UI intervention and nurse continence
programmes, can result in increased use of self-
management strategies, reductions in UI episodes
and incontinence pad usage, and improved HRQL
(51–55). Our goals in issuing this statement are to
discuss the importance of bladder health as a compo-
nent of overall health and to describe factors that
inﬂuence bladder health. The statement is directed
towards the general public, clinicians, policy makers
and public health ofﬁcials, and we believe that
increased education through a consensus statement
addressing major issues related to bladder health
may help improve overall bladder health.
We acknowledge that there are several challenges
associated with developing a consensus statement
regarding bladder health. It is difﬁcult to deﬁne or
describe ‘normal’ or ‘healthy’ bladder function, as it
is not simply the absence of disease. We also
acknowledge that the causal relationship between
bladder conditions and concomitant conditions are
not entirely understood, such as the relationship
between urgency UI and depression. Healthy habits
do not guarantee healthy, normal bladder function,
and normal function can be present despite poor
habits. In addition, there is a lack of research regard-
ing healthy bladder habits and⁄or normal bladder
function.
Many factors, both internal and external to the
individual, may inﬂuence bladder functioning. How-
ever, providing educational materials regarding
healthy habits and function to symptomatic individ-
uals seeking care, individuals who have symptoms
but are not seeking care, and asymptomatic individu-
als has been shown to improve health-seeking behav-
iours (51) and thus may be applicable to bladder
health. Finally, it is unclear whether all conditions
are preventable or whether it is only possible to delay
onset or reduce bothersome symptoms. Limited
research has been conducted for primary prevention
(education about behaviour changes and setting
expectations for normal urinary tract function) of
bladder dysfunction; most studies are focused on
secondary prevention (52,56).
Discussion
Understanding bladder anatomy
Understanding the anatomy and physiology of the
urinary system and what constitutes a healthy blad-
der, including its function, anatomy and potential
susceptibility to dysfunction, may help promote
bladder health. The bladder is a hollow muscular
organ that is lined by mucosa (urothelium) and is
sensitive to both urine volume and its chemical com-
position (Figure 1A–C). The kidneys ﬁlter blood to
remove excess water and waste products and produce
urine, which travel from the kidneys to the blad-
der through the ureters. Urine is stored in the
bladder until it is emptied through the urethra. The
bladder neck, external urethral sphincter and the
pelvic ﬂoor muscles help to maintain continence.
Healthy bladder functioning
A healthy bladder is free of bacterial infection or
tumours and stores urine without discomfort at low
pressure with intermittent signals of ﬁlling (57). Nor-
mal functional bladder capacity in adults ranges from
approximately 300 to 400 ml (58,59). Although the
International Continence Society deﬁnes urinary fre-
quency as the perception by the patient that he⁄she
voids too often (1), epidemiological studies suggest
that the normal micturition rate is approximately 8
micturitions per day and 1 or fewer episodes per
night (60). As such, small volumes with increased
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ﬁbres respond to increasing ﬁlling, and micturition
is prompted at or near bladder volume capacity
(approximately every 3–4 h based on volume of
liquid consumed). Voiding typically occurs via initial
relaxation of the pelvic ﬂoor muscles and the bladder
neck followed by voluntary contraction of the detru-
sor muscle. Healthy voiding occurs promptly with
strong continuous ﬂow and complete emptying with-
out pain or blood in the urine. When necessary, an
individual should be able to defer voiding without
leakage. Variations in any of these normal responses
may be a sign of disease.
Knowledge of the physical and functional aspects
of the bladder may help promote bladder health, as
well as treatment outcomes for bladder conditions.
For example, pelvic ﬂoor muscle exercises (also
known as Kegel exercises) may prevent and treat
mild stress incontinence (61–63). Many individuals
with OAB who were successfully treated with a com-
bination of behavioural interventions plus an
antimuscarinic after failing previous antimuscarinic
therapy cited information provided to them about
the bladder and pelvic ﬂoor muscles as an important
contributor to their treatment satisfaction (64). It is
anticipated that increasing knowledge about changes
in bladder health⁄function over time will help adults
to identify and seek treatment for bladder conditions.
Anatomically, functional bladder capacity increases
with age from childhood [(years of age + 2) · 30
ml] to adulthood (300–400 ml). Changes in the adult
bladder and pelvic ﬂoor muscles with ageing also
include decreased bladder sensation, decreased con-
tractility during voiding, decreased muscle tone in
pelvic ﬂoor muscles and increased residual volume
(57,65–70). Other physical changes include up-regu-
lation of purinergic receptors with increased preva-
lence of detrusor overactivity (71) and increased
acetylcholine release in the urothelium (71), both of
which can produce LUTS. The prevalence of LUTS
increases with age (4). While there are age-associated
changes to the bladder and its function, those effects
are minimal and easily compensated for by changes
in bladder habits. Troublesome or severe bladder
symptoms are not normal; therefore, the false belief
that incontinence, for example, is a natural, inevita-
ble consequence of ageing should be dispelled (72).
Inﬂuences on bladder function
Dietary inﬂuences
A number of factors inﬂuence bladder function (Fig-
ure 2). For example, some foods and beverages may
provoke bladder urgency or discomfort or stimulate
diuresis, including caffeine, carbonated beverages and
artiﬁcial sweeteners (73–77). Several types of bever-
ages and foods, including coffee, tea, soda, alcoholic
beverages, citrus fruits and juices, artiﬁcial sweeteners
Kidney
Ureter
Bladder
Urethra
Uterus
Ureter
Bladder
Urethra
Pubic bone
muscles
Ureter
Bladder
Urethra
Pubic bone
Prostate
muscles
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C
Figure 1 Urinary system (A) frontal view (woman), (B)
lateral view (woman) and (C) lateral view (man)
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with BPS⁄IC (78). The BPS⁄IC Ad Hoc Committee
on Diet has published a list of ‘bladder- and prostate-
friendly foods’ with the intent of helping people
determine and avoid foods that may trigger symp-
toms or compromise treatment efﬁcacy (79) and
AUA BPS⁄IC guidelines suggest avoidance of foods
and beverages which are known to be bladder irri-
tants, such as coffee and citrus products. The guide-
line also suggests using an elimination strategy to
identify foods that may cause or exacerbate symptoms
(2). Fluid intake may also affect bladder function.
Based on 3-day diary entries, ﬂuid intake averaging
> 3700 ml per day has been associated with voiding
frequency of > 10 times during the day and nearly
2 times at night, as well as higher incidence of UI,
compared with intake of approximately 2400 ml per
day (80). Some people may limit ﬂuid intake as a way
to cope with LUTS, including urgency, frequency and
UI (81–83). However, ﬂuid restriction may increase
urine concentration, leading to irritation of the blad-
der mucosa and increased incidence of LUTS and
UTI (84). The US Food Science Board recommended
that ﬂuid intake volume is 30 ml⁄kg per day or half
an ounce per pound per 24 h.
Pelvic ﬂoor functioning
Healthy pelvic ﬂoor function is important to having
a healthy bladder. Pelvic ﬂoor muscle training can be
used to alleviate UI and urgency and to extend the
interval between voids (85). Strengthening or learn-
ing to contract pelvic ﬂoor muscles may also increase
the efﬁcacy of pharmacotherapy (85,86). In a rando-
mised clinical trial, pelvic ﬂoor muscle training, pre-
emptive pelvic ﬂoor contraction to prevent leakage
and bladder training signiﬁcantly decreased UI and
voiding frequency 12 months postintervention (87).
In another study, education about pre-emptive pelvic
ﬂoor muscle contraction to prevent leakage (the
Knack maneuver) signiﬁcantly reduced UI in older
women and pregnant women (88). A systematic
review assessing the effect of pelvic ﬂoor muscle
training versus standard antenatal and postnatal care
concluded that pelvic ﬂoor muscle training may pre-
vent UI in late pregnancy and postpartum and may
effectively reduce persistent postpartum UI (89).
Timed voiding has also been employed with and
without other behavioural interventions for manag-
ing UI (90). A test of education about bladder train-
ing, pelvic ﬂoor muscle training and the Knack
maneuver is currently in progress to assess the pre-
ventive impact of these combined behavioural inter-
ventions.
Adult and childhood toileting habits
Toileting behaviours related to urination can con-
tribute to dysfunctional voiding habits. Identifying
and modifying the various components of voiding,
Healthy
bladder
Developmental
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childhood 
symptoms) 
Knowledge, 
science,
education
(healthy 
functioning,
PFMT, etc.)
Physical
(anatomy, 
constipation,
obesity, etc.)
Behavioral
(smoking, diet,
etc.)
Societal
(norms and 
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Environmental
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work) 
Personal
(concomitant 
conditions, 
etc.)
Figure 2 Factors inﬂuencing bladder health
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prevent, eliminate, reduce and⁄or manage LUTS
(91). Furthermore, toilet training rituals during
childhood may affect bladder health in adulthood
(92) and childhood urinary symptoms are signiﬁ-
cantly associated with adult bladder conditions
(93,94). An association has also been reported
between OAB symptoms in children and their birth
parents, with the fathers having stopped ‘bed wet-
ting’ at a signiﬁcantly later age than the fathers of
children without OAB and mothers of children
with OAB having similar symptoms in childhood
compared with mothers of children without OAB
(95).
Societal attitudes
Social⁄cultural attitudes may inﬂuence the response
to or perception of bladder function and may inter-
fere with treatment-seeking behaviour. LUTS such as
increased voiding frequency and urgency are associ-
ated with social limitation, loss of control of the
body and speculation as to the nature of a non-
speciﬁc ‘problem’ (96). UI and other LUTS are
associated with reduced HRQL, stigma and embar-
rassment (28,96–98). Bladder conditions may inter-
fere with cultural⁄religious rituals, resulting in
underreporting. For example, Jewish and Muslim
religions require an element of cleanliness for prayer
that is compromised by the perceived lack of cleanli-
ness associated with urinary incontinence (99).
Environmental inﬂuences
Environmental factors can also inﬂuence bladder
health. Work environments are required to provide
adequate access, cleanliness and safety for toilet facil-
ities (100); lack thereof can cause decreases in liquid
intake (101) or infrequent voiding (102) by workers
that can lead to compromised bladder function or
urinary tract infection. Occupational barriers exist
for individuals with paruresis (103), who experience
social anxiety associated with travel, work or inter-
personal relationships associated with the fear of
being unable to urinate in the presence of others. In
addition, attitudes and rules regarding toileting in
school may inﬂuence bladder habits. Teachers’
awareness of factors that contribute to bladder dys-
function in school-aged children is important
(104,105). Lack of awareness among teachers regard-
ing normal elimination patterns in children can lead
to restrictions on the frequency of children’s access
to bathroom facilities, which may have adverse
effects on bladder health (104). In addition, the bath-
rooms in schools are reportedly often lacking in pri-
vacy, cleanliness and safety (e.g. a place where
bullying may occur), which may contribute to urine-
holding behaviours and dysfunctional voiding
(104,106).
Physical factors
Physical inﬂuences on bladder health are less under-
stood. Bladder conditions can vary based on age,
gender, health history (107,108) and ethnicity (109–
111). For instance, it is well established that the
prevalence of all categories of LUTS increase with
age in men and women (4,112). Moreover, there are
differences between men and women in the LUTS
that they are likely to experience and in the bother
associated with LUTS (113–116). In the EPIC study,
a population-based, cross-sectional survey of UI,
OAB and other LUTS among people in ﬁve coun-
tries, the prevalence of storage LUTS tended to be
greater in women (59% vs. 51%), whereas the preva-
lence of voiding (26% vs. 20%) and postmicturition
(17% vs. 14%) LUTS tended to be higher in men
(4). Men may be more likely to experience bother
associated with UI than women (117).
UTI is more prevalent in women than men (118)
and a variety of factors affecting UTI in women may
be related to age. For example, in women, postmeno-
pausal status, sexual activity, history of UTI, treated
diabetes and UI are associated with a higher risk of
UTI (119,120). UTI in postmenopausal women has
been linked to several factors⁄conditions that are
associated with a decrease in oestrogen, including
vaginal prolapse, elevated postvoid residual urine
volume and urinary incontinence. Treatment with
oestrogen results in increased glycogen production in
the vaginal tissues providing an acidic environment
for lactobacilli and other normal pathogens to thrive.
Low oestrogen levels result in alterations in pH and
promotion of growth of enteric bacteria associated
with UTI. Treatment with vaginal oestrogen vs. pla-
cebo has shown promise for utilisation of oestrogen
for reducing the incidence of recurrent UTI (121).
At clinical presentation, postmenopausal women are
more likely than younger women to report ﬂank
pain, whereas younger women are more likely than
postmenopausal women to report frequency, dysuria,
haematuria and fever (122). BPS⁄IC may also be
more prevalent in women than in men (123). Blad-
der cancer is more prevalent in men than in women
and the risk of bladder cancer increases with age in
both genders (13).
Concomitant conditions
Bladder health may also be inﬂuenced by secondary
effects of pregnancy (124) and childbirth (124–127)
and by a number of conditions or comorbidities,
such as obesity (128,129), diabetes (130), hyperten-
sion⁄heart failure (101,130) and constipation. Fur-
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not only reportedly associated with increased rates of
incontinence but increase the difﬁculty of managing
UI symptoms (131). For example, dementia has been
shown to be an independent predictor of UI (132).
In addition, many medications prescribed for comor-
bidities (e.g. sympathomimetics, tricyclic antidepres-
sants, a-adrenergic blockers and angiotensin
converting enzyme inhibitors) may affect continence
(133). Although urinary incontinence is prevalent in
patients with heart failure and⁄or comorbid diabetes,
patients vary with regard to health-seeking behav-
iours to address urinary incontinence thereby requir-
ing different types⁄levels of education (130). Obesity
is associated with LUTS, including stress, mixed and
urgency UI (128,134,135). Likewise, weight loss is
associated with improvements in incontinence status
(128,136). Although the exact mechanisms linking
the two conditions has not been completely eluci-
dated, results of the Program to Reduce Incontinence
by Diet and Exercise (PRIDE) study indicate an asso-
ciation between BMI and abdominal circumference
with intra-abdominal and intravesical pressure (137).
Shared neural pathways for the bladder and bowel
may play a role in OAB symptoms (138,139); indi-
viduals with constipation are more likely to develop
OAB symptoms than those who are not constipated
(140). Furthermore, constipation and OAB are asso-
ciated with uterovaginal prolapse; in a study of 320
women with LUTS (40% with OAB), 16% had faecal
incontinence (FI) and 32% had constipation (141).
Finally, bladder cancer is more common in individu-
als with a history of smoking, exposure to aniline
dyes, history of chronic bladder inﬂammation, prior
pelvic irradiation (such as for prostate cancer or
gynaecological malignancies), chemotherapy with
cyclophosphamide (cytoxan) or ifosfamide (ifex) and
in those with chronically low ﬂuid consumption.
Conversely, there may be collateral physical bene-
ﬁts of enhanced bladder health. The increased risk of
falls and fractures in patients with OAB or urgency
UI is thought to be largely attributable to the act of
rushing to the bathroom. Thus, treatment of OAB
and UI may be associated with decreased fall risk.
(35,142,143). Additional beneﬁts of healthy bladder
habits may include improved sexual function.
Enhanced sexual pleasure is most plausibly linked to
greater pelvic muscle strength and control ensuing
from an exercise regimen recommended to reduce
UI. Research is sparse, but results of two studies pro-
vide some support. Midlife women with stress UI
who completed a 6-month programme of pelvic
ﬂoor muscle training reported fewer problems with
sexual dysfunction related to UI (144). Midlife
women who completed a 12-month programme of
pelvic ﬂoor muscle training reported signiﬁcantly
higher levels of sexual satisfaction compared with
controls (145).
An important modiﬁable behaviour associated
with poor bladder health is smoking. There are
strong associations between smoking and LUTS
(146–149) and the risk of bladder cancer has been
reported to be increased twofold in smokers with an
increase in risk with increasing amounts of smoking
(150) and longer duration (151). In addition, smok-
ing cessation has positive impact on overall health
and related quality of life and should universally be
encouraged.
Potential beneﬁts of the consensus statement
on bladder health
This statement is intended to raise awareness of blad-
der health by stimulating discussion on this topic
and primary prevention research in the form of epi-
demiological studies, educational needs assessment
and community-based public health initiatives. Pri-
mary preventions are intended to prevent expected
health problems, to maintain existing states of health
and healthy functioning and to promote desired out-
comes (56,152). Thus, initiatives that disseminate
information about healthy bladder function may give
rise to adoption of practices that promote bladder
health.
The desired outcome of increased awareness of
healthy bladder habits is a reduction in negative out-
comes associated with bladder conditions including
nursing home admittance, falls and impaired HRQL
(17,35,142,143). Individuals with healthy habits may
still develop bladder conditions; however, knowledge
of the physical and functional aspects of the bladder
may help mitigate the sequelae of underreported, un-
derdiagnosed and undertreated bladder symptoms.
Identiﬁcation and awareness of risk factors, including
smoking and obesity, is likely to be an important
part of primary prevention of bladder conditions. In
addition, bladder health education may increase
screening for bladder cancer, BPS⁄IC, early and tran-
sient UI and UTIs, for which some diagnoses are
ambiguous. For BPS⁄IC in particular, there remains
a lack of consensus on diagnosis based on the lack of
a diagnostic instrument to accurately diagnose the
condition, which may be attributable at least in part
to the overlap in symptomatology, including pelvic
pain and UI, with various other conditions (e.g.
ﬁbromyalgia, endometriosis, irritable bowel syn-
drome and recurrent UTIs) (5). Education, however,
should improve outcomes and⁄or perceptions about
bladder health. A study evaluating the effect of an
education intervention, including information about
OAB, medication use and behavioural therapy,
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tion therapies and self-perception of treatment out-
come were signiﬁcantly enhanced compared with
controls (153). Adherence with a self-management
practice such as pelvic ﬂoor muscle training has been
associated with adherence to bladder training as well
(154).
Many people with bladder conditions tend not
to report related symptoms to healthcare providers
and use multiple coping mechanisms as opposed
to seeking professional treatment (155). Various
health risks are associated with avoidance of
healthcare seeking, including UI progression and
recurrence of UTI (155). Men and women vary
with regard to perception of bother and health-
care-seeking behaviours (113). Raising awareness
can help reduce the stigma associated with bladder
conditions, which is a barrier to bladder health
that can compromise outcomes and reduce HRQL
(156). Improving the basic understanding of nor-
mal bladder function and treatment options for
conditions⁄disease may result in increased care-
seeking behaviours. Education can help reduce the
stigma associated with LUTS (96). Increasing phy-
sician, nurse practitioner and physician assistant
education about the importance of bladder health
may also increase clinician engagement by combat-
ing various barriers to clinician involvement (e.g.
limited reimbursement for prevention, lack of clini-
cian training, etc.).
An anticipated beneﬁt from this consensus state-
ment is to raise awareness among the Public Health
world regarding bladder health in the context of
overall health, to help lay the ground work for a
world-wide public health initiative (157). One limita-
tion of this initial statement is that it is based on the
US perspective, because, globally, the impact of the
inﬂuencers will vary. In addition, the authors of this
statement acknowledge gaps in the available litera-
ture. Lastly, the authors of this statement do not
intend it to be a comprehensive review of all data
related to bladder health.
Summary
Bladder health is a key component of overall health.
Internal and external factors inﬂuence bladder health.
Primary prevention through education regarding
normal bladder structures and functioning can help
promote healthy bladder habits and early treatment
seeking for bladder conditions. Our goal is to raise
awareness about bladder health that, in turn, will
reduce the associated personal, societal and economic
burden, including anxiety and depression related to
stigma and costs associated with bladder conditions.
Increases in healthcare-seeking behaviours should
result from knowledge that most bladder conditions
are treatable and a range of treatment options exist,
including self-management.
Promoting and achieving optimal bladder health
can help minimise the effects of bladder conditions
on the affected population, healthcare professionals,
educators, employers and payors. Previous bladder
health initiatives have focused largely on primary
prevention of incontinence, often exclusively in
women. This is the ﬁrst US public health statement
to address bladder health and is intended to promote
wide-spread bladder health awareness in the context
of overall health. Consensus was reached that there
are established clinical directives that are generally
agreed upon to promote and maintain bladder
health. These include: (i) consume an adequate
amount of ﬂuid (25–30 ml⁄kg per day, the amount
needed to empty the bladder every 3 to 4 h), (ii)
moderate consumption of foods or beverages known
to irritate the bladder, (iii) adopt a relaxed position
for urination and allow time for the bladder to
empty, (iv) use self-management practices of pelvic
ﬂoor muscle training, bladder training and pre-emp-
tive pelvic ﬂoor contraction to improve and maintain
bladder health, (v) avoid constipation, (vi) avoid
obesity; and (vii) do not smoke.
Acknowledgements and funding
The authors gratefully acknowledge Ananias Diokno,
MD, William Beaumont Hospital, Royal Oak, MI,
USA; Kathryn Burgio, PhD, Birmingham⁄Atlanta
Geriatric Research, Education and Clinical Center,
Department of Veterans Affairs Medical Center and
University of Alabama at Birmingham, AL, USA; and
Diane Newman, RNC, MSN, Division of Urology,
University of Pennsylvania Health System, Philadel-
phia, PA, USA for their participation on the expert
panel. The authors also wish to acknowledge Nicole
Lodowski, MPH, New York University and Research
Associate, Pﬁzer Inc., New York, NY, USA and
Tamara Bavendam, MD, MSc, Pﬁzer Inc., New York,
NY, USA for contributing valuable discussion. Medi-
cal writing assistance was provided by Nancy Sheri-
dan and Colin Mitchell of Complete Healthcare
Communications Inc. and was funded by Pﬁzer Inc.
Authors’ contributions
ESL, CS, MG, SM, MR, PE and MHP contributed to
concept development, writing and critical review of
the manuscript.
Consensus statement – a healthy bladder 1033
ª 2011 Blackwell Publishing Ltd Int J Clin Pract, October 2011, 65, 10, 1026–1036References
1 Abrams P, Cardozo L, Fall M et al. The stan-
dardisation of terminology of lower urinary tract
function: report from the Standardisation Sub-
committee of the International Continence Society.
Neurourol Urodyn 2002; 21: 167–78.
2 Hanno PM, Burks DA, Clemens JQ et al. AUA
guideline for the diagnosis and treatment of inter-
stitial cystitis ⁄ bladder pain syndrome. JU r o l2011;
185: 2162–70.
3 Irwin DE, Kopp ZS, Agatep B et al. Worldwide
prevalence estimates of lower urinary tract symp-
toms, overactive bladder, urinary incontinence and
bladder outlet obstruction. BJU Int 2011; doi:
10.1111/j.1464-410X.2010.09993.x.
4 Irwin DE, Milsom I, Hunskaar S et al. Population-
based survey of urinary incontinence, overactive
bladder, and other lower urinary tract symptoms
in ﬁve countries: results of the EPIC study. Eur
Urol 2006; 50: 1306–15.
5 Butrick CW, Howard FM, Sand PK. Diagnosis and
treatment of interstitial cystitis ⁄ painful bladder
syndrome: a review. J Womens Health (Larchmt)
2010; 19: 1185–93.
6 Clemens JQ, Link CL, Eggers PW et al. Prevalence
of painful bladder symptoms and effect on quality
of life in black, Hispanic and White men and
women. J Urol 2007; 177: 1390–4.
7 Berry SH, Stoto MA, Elliott M et al. Prevalence of
interstitial cystitis ⁄painful bladder syndrome in
the United States. J Urol 2009; 181: 20–1.
8 Schmiemann G, Kniehl E, Gebhardt K et al. The
diagnosis of urinary tract infection: a systematic
review. Dtsch Arztebl Int 2010; 107: 361–7.
9 Dielubanza EJ, Schaeffer AJ. Urinary tract infec-
tions in women. Med Clin North Am 2011; 95:
27–41.
10 Jacobs BL, Lee CT, Montie JE. Bladder cancer in
2010: how far have we come? CA Cancer J Clin
2010; 60: 244–72.
11 Kakehi Y, Hirao Y, Kim WJ et al. Bladder cancer
working group report. Jpn J Clin Oncol 2010;
40(Suppl 1): i57–64.
12 Sexton WJ, Wiegand LR, Correa JJ et al. Bladder
cancer: a review of non-muscle invasive disease.
Cancer Control 2010; 17: 256–68.
13 Shariat SF, Sfakianos JP, Droller MJ et al. The
effect of age and gender on bladder cancer: a criti-
cal review of the literature. BJU Int 2010; 105:
300–8.
14 Subak LL, Brown JS, Kraus SR et al. The ‘costs’ of
urinary incontinence for women. Obstet Gynecol
2006; 107: 908–16.
15 Subak LL, Brubaker L, Chai TC et al. High costs
of urinary incontinence among women electing
surgery to treat stress incontinence. Obstet Gynecol
2008; 111: 899–907.
16 Morrison A, Levy R. Fraction of nursing home
admissions attributable to urinary incontinence.
Value Health 2006; 9: 272–4.
17 Nuotio M, Tammela TL, Luukkaala T, Jylha M.
Predictors of institutionalization in an older popu-
lation during a 13-year period: the effect of urge
incontinence. J Gerontol A Biol Sci Med Sci 2003;
58: 756–62.
18 Ganz ML, Smalarz AM, Krupski TL et al. Eco-
nomic costs of overactive bladder in the United
States. Urology 2010; 75: 526–32, 32 e1–18.
19 Stanford EJ, Chen A, Wan GJ et al. Treatment
modalities, health care resource utilization, and
costs in patients diagnosed with interstitial cystitis.
Am J Obstet Gynecol 2008; 199: 71 e1–10.
20 Clemens JQ, Markossian T, Calhoun EA. Compar-
ison of economic impact of chronic prostati-
tis ⁄ chronic pelvic pain syndrome and interstitial
cystitis ⁄ painful bladder syndrome. Urology 2009;
73: 743–6.
21 Foxman B. Epidemiology of urinary tract infec-
tions: incidence, morbidity, and economic costs.
Dis Mon 2003; 49: 53–70.
22 Spencer JD, Schwaderer A, McHugh K, Hains DS.
Pediatric urinary tract infections: an analysis of
hospitalizations, charges, and costs in the USA.
Pediatr Nephrol 2010; 25: 2469–75.
23 Sievert KD, Amend B, Nagele U et al. Economic
aspects of bladder cancer: what are the beneﬁts
and costs? World J Urol 2009; 27: 295–300.
24 Bartoli S, Aguzzi G, Tarricone R. Impact on qual-
ity of life of urinary incontinence and overactive
bladder: a systematic literature review. Urology
2010; 75: 491–500.
25 Constitution of the World Health Organization.
2006 Available at: http://www.who.int/governance/
eb/who_constitution_en.pdf.(accessed 28 April
2011).
26 Coyne KS, Sexton CC, Irwin DE et al. The impact
of overactive bladder, incontinence and other
lower urinary tract symptoms on quality of life,
work productivity, sexuality and emotional well-
being in men and women: results from the EPIC
study. BJU Int 2008; 101: 1388–95.
27 Sexton CC, Coyne KS, Vats V et al. Impact of
overactive bladder on work productivity in the
United States: results from EpiLUTS. Am J Manag
Care 2009; 15: S98–107.
28 Coyne KS, Zhou Z, Thompson C, Versi E. The
impact on health-related quality of life of stress,
urge and mixed urinary incontinence. BJU Int
2003; 92: 731–5.
29 Kraus SR, Bavendam T, Brake T, Griebling TL.
Vulnerable elderly patients and overactive bladder
syndrome. Drugs Aging 2010; 27: 697–713.
30 Markland AD, Goode PS, Redden DT et al. Preva-
lence of urinary incontinence in men: results from
the national health and nutrition examination sur-
vey. J Urol 2010; 184: 1022–7.
31 Melville JL, Delaney K, Newton K, Katon W. Incon-
tinence severity and major depression in inconti-
nent women. Obstet Gynecol 2005; 106: 585–92.
32 Melville JL, Fan MY, Rau H et al. Major depres-
sion and urinary incontinence in women: temporal
associations in an epidemiologic sample. Am J
Obstet Gynecol 2009; 201: 490 e1–7.
33 Sung VW, West DS, Hernandez AL et al. Associa-
tion between urinary incontinence and depressive
symptoms in overweight and obese women. Am J
Obstet Gynecol 2009; 200: 557 e1–5.
34 Zorn BH, Montgomery H, Pieper K et al. Urinary
incontinence and depression. J Urol 1999; 162:
82–4.
35 Jacome C, Oliveira D, Marques A, Sa-Couto P.
Prevalence and impact of urinary incontinence
among female athletes. Int J Gynaecol Obstet 2011;
114: 60–3.
36 Nygaard IE, Thompson FL, Svengalis SL, Albright
JP. Urinary incontinence in elite nulliparous ath-
letes. Obstet Gynecol 1994; 84: 183–7.
37 Carls C. The prevalence of stress urinary inconti-
nence in high school and college-age female ath-
letes in the midwest: implications for education
and prevention. Urologic Nursing 2007; 27: 21–4.
38 Thyssen HH, Clevin L, Olesen S, Lose G. Urinary
incontinence in elite female athletes and dancers. Int
Urogynecol J Pelvic Floor Dysfunct 2002; 13: 15–7.
39 Bo K, Bratland-Sanda S, Sundgot-Borgen J. Uri-
nary incontinence among group ﬁtness instructors
including yoga and pilates teachers. Neurourol
Urodyn 2011; 30: 370–3.
40 Larsen WI, Yavorek TA. Pelvic organ prolapse and
urinary incontinence in nulliparous women at the
United States Military Academy. Int Urogynecol J
Pelvic Floor Dysfunct 2006; 17: 208–10.
41 Darkow T, Fontes CL, Williamson TE. Costs asso-
ciated with the management of overactive bladder
and related comorbidities. Pharmacotherapy 2005;
25: 511–9.
42 Nickel JC, Tripp DA, Pontari M et al. Interstitial
cystitis ⁄painful bladder syndrome and associated
medical conditions with an emphasis on irritable
bowel syndrome, ﬁbromyalgia and chronic fatigue
syndrome. J Urol 2010; 184: 1358–63.
43 Nygaard I, Girts T, Fultz NH et al. Is urinary
incontinence a barrier to exercise in women?
Obstet Gynecol 2005; 106: 307–14.
44 Anger JT, Zabihi N, Clemens JQ et al. Treatment
choice, duration, and cost in patients with intersti-
tial cystitis and painful bladder syndrome. Int Uro-
gynecol J Pelvic Floor Dysfunct 2011; 22: 395–400.
45 Botteman MF, Pashos CL, Hauser RS et al. Quality
of life aspects of bladder cancer: a review of the
literature. Qual Life Res 2003; 12: 675–88.
46 Gilbert SM, Wood DP, Dunn RL et al. Measuring
health-related quality of life outcomes in bladder
cancer patients using the Bladder Cancer Index
(BCI). Cancer 2007; 109: 1756–62.
47 Latini DM, Lerner SP, Wade SW et al. Bladder
cancer detection, treatment and outcomes: oppor-
tunities and challenges. Urology 2010; 75: 334–9.
48 Wright JL, Porter MP. Quality-of-life assessment
in patients with bladder cancer. Nat Clin Pract
Urol 2007; 4: 147–54.
49 Benner JS, Becker R, Fanning K et al. Bother
related to bladder control and health care seeking
behavior in adults in the United States. J Urol
2009; 181: 2591–8.
50 Newman DK, Ee CH, Gordon D et al. Continence
promotion, education & primary prevention. In:
Abrams P, Cardozo L, Khoury S, Wein A, eds.
Incontinence, Proceedings from the 4th International
Consultation on Incontinence. Plymouth, UK:
Health Publication, 2009: 1643–84.
51 O’Connell B, Wellman D, Baker L, Day K. Does a
continence educational brochure promote health-
seeking behavior? J Wound Ostomy Continence
Nurs 2006; 33: 389–95.
52 Palmer MH. A health-promotion perspective of
urinary continence. Nurs Outlook 1994; 42: 163–9.
53 McFall SL, Yerkes AM, Cowan LD. Outcomes of a
small group educational intervention for urinary
incontinence: health-related quality of life. J Aging
Health 2000; 12: 301–17.
54 Borrie MJ, Bawden M, Speechley M, Kloseck M.
Interventions led by nurse continence advisers in
the management of urinary incontinence: a ran-
domized controlled trial. CMAJ 2002; 166: 1267–
73.
1034 Consensus statement – a healthy bladder
ª 2011 Blackwell Publishing Ltd Int J Clin Pract, October 2011, 65, 10, 1026–103655 Albers-Heitner CP, Lagro-Janssen ALM, Joore MA
et al. Effectiveness of involving a nurse specialist
for patients with urinary incontinence in primary
care: results of a pragmatic multicentre rando-
mised controlled trial. Int J Clin Pract 2011; 65:
705–12.
56 Palmer MH. Primary prevention research on
incontinence in older adults. West J Nurs Res
2002; 24: 390–405.
57 Fry CH. Role of the bladder in storage and mictu-
rition. Surgery, 23: 93–6.
58 Fitzgerald MP, Stablein U, Brubaker L. Urinary
habits among asymptomatic women. Am J Obstet
Gynecol 2002; 187: 1384–8.
59 Latini JM, Mueller E, Lux MM et al. Voiding fre-
quency in a sample of asymptomatic American
men. J Urol 2004; 172: 980–4.
60 Lukacz ES, Whitcomb EL, Lawrence JM et al. Uri-
nary frequency in community-dwelling women:
what is normal? Am J Obstet Gynecol 2009; 200:
552 e1–7.
61 Dumoulin C, Hay-Smith J. Pelvic ﬂoor muscle
training versus no treatment, or inactive control
treatments, for urinary incontinence in women.
Cochrane Database Syst Rev 2010; 1: CD005654.
62 Huebner M, Riegel K, Hinninghofen H et al. Pel-
vic ﬂoor muscle training for stress urinary inconti-
nence: A randomized, controlled trial comparing
different conservative therapies. Physiother Res Int
2010; doi: 10.1002/pri.489.
63 Herbruck LF. Stress urinary incontinence: preven-
tion, management, and provider education. Urol
Nurs 2008; 28: 200–6; quiz 7.
64 Wyman JF, Harding G, Klutke C et al. Contribu-
tors to satisfaction with combined drug and
behavioral therapy for overactive bladder in sub-
jects dissatisﬁed with prior drug treatment. J
Wound Ostomy Continence Nurs 2010; 37: 199–
205.
65 DuBeau C, Kuchel GA, Johnson T et al. Inconti-
nence in the frail elderly. In: Abrams P, Cardozo
L, Khoury S, Wein A, eds. Incontinence, 4th edn.
Paris: Editions 21, for Health Publication Ltd,
2009: 963–1024.
66 Jansson UB, Hanson M, Sillen U, Hellstrom AL.
Voiding pattern and acquisition of bladder control
from birth to age 6 years – a longitudinal study. J
Urol 2005; 174: 289–93.
67 Kaefer M, Zurakowski D, Bauer SB et al. Estimat-
ing normal bladder capacity in children. J Urol
1997; 158: 2261–4.
68 Mitteness LS. Knowledge and beliefs about urinary
incontinence in adulthood and old age. J Am Geri-
atr Soc 1990; 38: 374–8.
69 Miller YD, Brown WJ, Smith N, Chiarelli P. Man-
aging urinary incontinence across the lifespan. Int
J Behav Med 2003; 10: 143–61.
70 Pﬁsterer MH, Grifﬁths DJ, Schaefer W, Resnick
NM. The effect of age on lower urinary tract func-
tion: a study in women. J Am Geriatr Soc 2006;
54: 405–12.
71 Yoshida M, Miyamae K, Iwashita H et al. Manage-
ment of detrusor dysfunction in the elderly:
changes in acetylcholine and adenosine triphos-
phate release during aging. Urology 2004; 63: 17–
23.
72 Mitteness LS, Barker JC. Stigmatizing a ‘normal’
condition: urinary incontinence in late life. Med
Anthropol Q 1995; 9: 188–210.
73 Lee JG, Wein AJ, Levin RM. The effect of caffeine
on the contractile response of the rabbit urinary
bladder to ﬁeld stimulation. Gen Pharmacol 1993;
24: 1007–11.
74 Arya LA, Myers DL, Jackson ND. Dietary caffeine
intake and the risk for detrusor instability: a case-
control study. Obstet Gynecol 2000; 96: 85–9.
75 Dallosso HM, McGrother CW, Matthews RJ, Don-
aldson MM. The association of diet and other life-
style factors with overactive bladder and stress
incontinence: a longitudinal study in women. BJU
Int 2003; 92: 69–77.
76 Dasgupta J, Elliott RA, Doshani A, Tincello DG.
Enhancement of rat bladder contraction by artiﬁ-
cial sweeteners via increased extracellular Ca
2+
inﬂux. Toxicol Appl Pharmacol 2006; 217: 216–24.
77 Lohsiriwat S, Hirunsai M, Chaiyaprasithi B. Effect
of caffeine on bladder function in patients with
overactive bladder symptoms. Urol Ann 2011; 3:
14–8.
78 Shorter B, Lesser M, Moldwin RM, Kushner L.
Effect of comestibles on symptoms of interstitial
cystitis. J Urol 2007; 178: 145–52.
79 IC ⁄PBS Ad Hoc Committee on Diet. 2009 IC ⁄PBS
food list: bladder and prostate friendly foods. 2009.
http://www.ic-network.com/diet/2009icdietlist.pdf
(accessed 16 May 2010).
80 Miller JM, Guo Y, Rodseth SB. Cluster analysis of
intake, output, and voiding habits collected from
diary data. Nurs Res 2011; 60: 115–23.
81 Anders K. Coping strategies for women with uri-
nary incontinence. Baillieres Best Pract Res Clin
Obstet Gynaecol 2000; 14: 355–61.
82 Ricci JA, Baggish JS, Hunt TL et al. Coping strate-
gies and health care-seeking behavior in a US
national sample of adults with symptoms sugges-
tive of overactive bladder. Clin Ther 2001; 23:
1245–59.
83 Swithinbank L, Hashim H, Abrams P. The effect
of ﬂuid intake on urinary symptoms in women.
J Urol 2005; 174: 187–9.
84 Beetz R. Mild dehydration: a risk factor of urinary
tract infection? Eur J Clin Nutr 2003; 57(Suppl 2):
S52–8.
85 Wyman JF, Burgio KL, Newman DK. Practical
aspects of lifestyle modiﬁcations and behavioural
interventions in the treatment of overactive blad-
der and urgency urinary incontinence. Int J Clin
Pract 2009; 63: 1177–91.
86 Klutke CG, Burgio KL, Wyman JF et al. Combined
effects of behavioral intervention and tolterodine
in patients dissatisﬁed with overactive bladder
medication. J Urol 2009; 181: 2599–607.
87 Diokno AC, Sampselle CM, Herzog AR et al. Pre-
vention of urinary incontinence by behavioral
modiﬁcation program: a randomized, controlled
trial among older women in the community.
J Urol 2004; 171: 1165–71.
88 Miller JM, Sampselle C, Ashton-Miller J et al.
Clariﬁcation and conﬁrmation of the Knack
maneuver: the effect of volitional pelvic ﬂoor mus-
cle contraction to preempt expected stress inconti-
nence. Int Urogynecol J Pelvic Floor Dysfunct 2008;
19: 773–82.
89 Hay-Smith J, Mørkved S, Fairbrother KA, Herbi-
son GP. Pelvic ﬂoor muscle training for preven-
tion and treatment of urinary and faecal
incontinence in antenatal and postnatal women.
Cochrane Database Syst Rev 2008; 4: CD007471.
90 Ostaszkiewicz J, Roe B, Johnston L. Effects of
timed voiding for the management of urinary
incontinence in adults: systematic review. J Adv
Nurs 2005; 52: 420–31.
91 Wang K, Palmer MH. Women’s toileting behav-
iour related to urinary elimination: concept analy-
sis. J Adv Nurs 2010; 66: 1874–84.
92 Wu HY. Achieving urinary continence in children.
Nat Rev Urol 2010; 7: 371–7.
93 Fitzgerald MP, Thom DH, Wassel-Fyr C et al.
Childhood urinary symptoms predict adult over-
active bladder symptoms. J Urol 2006; 175: 989–
93.
94 Minassian VA, Lovatsis D, Pascali D et al. Effect
of childhood dysfunctional voiding on urinary
incontinence in adult women. Obstet Gynecol 2006;
107: 1247–51.
95 Labrie J, de Jong TP, Nieuwhof-Leppink A et al.
The relationship between children with voiding
problems and their parents. J Urol 2010; 183:
1887–91.
96 Elstad EA, Taubenberger SP, Botelho EM, Tenn-
stedt SL. Beyond incontinence: the stigma of
other urinary symptoms. J Adv Nurs 2010; 66:
2460–70.
97 Liberman JN, Hunt TL, Stewart WF et al. Health-
related quality of life among adults with symptoms
of overactive bladder: results from a US commu-
nity-based survey. Urology 2001; 57: 1044–50.
98 Wilson MM. Urinary incontinence: a treatise on
gender, sexuality, and culture. Clin Geriatr Med
2004; 20: 565–70, ix.
99 Chaliha C, Stanton SL. The ethnic cultural and
social aspects of incontinence – a pilot study. Int
Urogynecol J Pelvic Floor Dysfunct 1999; 10: 166–
70.
100 Palmer MH, Hardin SR, Behrend C et al. Urinary
incontinence and overactive bladder in patients
with heart failure. J Urol 2009; 182: 196–202.
101 Nygaard I, Linder M. Thirst at work – an occupa-
tional hazard? Int Urogynecol J Pelvic Floor Dys-
funct 1997; 8: 340–3.
102 Bendtsen AL, Andersen JR, Andersen JT. Infre-
quent voiders syndrome (nurses bladder). Preva-
lence among nurses and assistant nurses in a
surgical ward. Scand J Urol Nephrol 1991; 25: 201–
4.
103 Soifer S, Himle J, Walsh K. Paruresis (shy bladder
syndrome): a cognitive-behavioral treatment
approach. Soc Work Health Care 2010; 49: 494–
507.
104 Boyt MA. Teachers’ knowledge of normal and
abnormal elimination patterns in elementary
school children. J Sch Nurs 2005; 21: 346–9.
105 Lundblad B, Hellstrom AL, Berg M. Children’s
experiences of attitudes and rules for going to the
toilet in school. Scand J Caring Sci 2010; 24: 219–
23.
106 Vernon S, Lundblad B, Hellstrom AL. Children’s
experiences of school toilets present a risk to their
physical and psychological health. Child Care
Health Dev 2003; 29: 47–53.
107 O’Connell B, Baker L, Munro I. The nature and
impact of incontinence in men who have under-
gone prostate surgery and implications for nursing
practice. Contemp Nurse 2007; 24: 65–78.
108 Chen GD, Lin LY, Wang PH, Lee HS. Urinary
tract dysfunction after radical hysterectomy for
cervical cancer. Gynecol Oncol 2002; 85: 292–7.
Consensus statement – a healthy bladder 1035
ª 2011 Blackwell Publishing Ltd Int J Clin Pract, October 2011, 65, 10, 1026–1036109 Thom DH, van den Eeden SK, Ragins AI et al.
Differences in prevalence of urinary incontinence
by race ⁄ ethnicity. J Urol 2006; 175: 259–64.
110 Graham CA, Mallett VT. Race as a predictor of
urinary incontinence and pelvic organ prolapse.
Am J Obstet Gynecol 2001; 185: 116–20.
111 Duong TH, Korn AP. A comparison of urinary
incontinence among African American, Asian, His-
panic, and White women. Am J Obstet Gynecol
2001; 184: 1083–6.
112 Kupelian V, Wei JT, O’Leary MP et al. Prevalence
of lower urinary tract symptoms and effect on
quality of life in a racially and ethnically diverse
random sample: the Boston Area Community
Health (BACH) Survey. Arch Intern Med 2006;
166: 2381–7.
113 Apostolidis A, Kirana PS, Chiu G et al. Gender
and age differences in the perception of bother
and health care seeking for lower urinary tract
symptoms: results from the hospitalised and out-
patients’ proﬁle and expectations study. Eur Urol
2009; 56: 937–47.
114 Kristiansen NK, Ringgaard S, Nygaard H, Djur-
huus JC. Effect of bladder volume, gender and
body position on the shape and position of the
urinary bladder. Scand J Urol Nephrol 2004; 38:
462–8.
115 Pauwels E, De Wachter S, Wyndaele JJ. Normality
of bladder ﬁlling studied in symptom-free middle-
aged women. JU r o l2004; 171: 1567–70.
116 Schmidt F, Shin P, Jorgensen TM et al. Urody-
namic patterns of normal male micturition: inﬂu-
ence of water consumption on urine production
and detrusor function. J Urol 2002; 168: 1458–
63.
117 Irwin DE, Milsom I, Kopp Z, Abrams P. Symptom
bother and health care-seeking behavior among
individuals with overactive bladder. Eur Urol 2008;
53: 1029–37.
118 Warren JW, Brown V, Jacobs S et al. Urinary tract
infection and inﬂammation at onset of interstitial
cystitis ⁄ painful bladder syndrome. Urology 2008;
71: 1085–90.
119 Jackson SL, Scholes D, Boyko EJ et al. Predictors
of urinary incontinence in a prospective cohort of
postmenopausal women. Obstet Gynecol 2006; 108:
855–62.
120 Moore EE, Hawes SE, Scholes D et al. Sexual
intercourse and risk of symptomatic urinary tract
infection in post-menopausal women. J Gen Intern
Med 2008; 23: 595–9.
121 Perrotta C, Aznar M, Mejia R et al. Oestrogens for
preventing recurrent urinary tract infection in
postmenopausal women. Cochrane Database Syst
Rev 2008; 2: CD005131.
122 Foxman B. Urinary tract infection in postmeno-
pausal women. Curr Infect Dis Rep 1999; 1: 367–70.
123 Hall SA, Link CL, Pulliam SJ et al. The relation-
ship of common medical conditions and medica-
tion use with symptoms of painful bladder
syndrome: results from the Boston area commu-
nity health survey. J Urol 2008; 180: 593–8.
124 Persson J, Wolner-Hanssen P, Rydhstroem H.
Obstetric risk factors for stress urinary inconti-
nence: a population-based study. Obstet Gynecol
2000; 96: 440–5.
125 Meyer S, Schreyer A, De Grandi P, Hohlfeld P.
The effects of birth on urinary continence mecha-
nisms and other pelvic-ﬂoor characteristics. Obstet
Gynecol 1998; 92: 613–8.
126 Hannah ME, Hannah WJ, Hodnett ED et al. Out-
comes at 3 months after planned cesarean vs
planned vaginal delivery for breech presentation at
term: the international randomized Term Breech
Trial. JAMA 2002; 287: 1822–31.
127 Hirsch AG, Minassian VA, Dilley A et al. Parity is
not associated with urgency with or without uri-
nary incontinence. Int Urogynecol J Pelvic Floor
Dysfunct 2010; 21: 1095–102.
128 Subak LL, Richter HE, Hunskaar S. Obesity and
urinary incontinence: epidemiology and clinical
research update. JU r o l2009; 182: S2–7.
129 Townsend MK, Danforth KN, Rosner B et al.
Body mass index, weight gain, and incident uri-
nary incontinence in middle-aged women. Obstet
Gynecol 2007; 110: 346–53.
130 Hawkins SY, Park J, Palmer MH. Interest in infor-
mation about urinary incontinence among diabetic
and nondiabetic heart failure patients. J Wound
Ostomy Continence Nurs 2010; 37: 536–41.
131 Huang AJ, Brown JS, Thom DH et al. Urinary
incontinence in older community-dwelling
women: the role of cognitive and physical function
decline. Obstet Gynecol 2007; 109: 909–16.
132 Miu DK, Lau S, Szeto SS. Etiology and predictors
of urinary incontinence and its effect on quality of
life. Geriatr Gerontol Int 2010; 10: 177–82.
133 Coyne KS, Cash B, Kopp Z et al. The prevalence
of chronic constipation and faecal incontinence
among men and women with symptoms of over-
active bladder. BJU Int 2011; 107: 254–61.
134 Hannestad YS, Rortveit G, Daltveit AK, Hunskaar
S. Are smoking and other lifestyle factors associ-
ated with female urinary incontinence? The Nor-
wegian EPINCONT Study. BJOG 2003; 110: 247–
54.
135 Chancellor MB, Oefelein MG, Vasavada S. Obesity
is associated with a more severe overactive bladder
disease state that is effectively treated with once-
daily administration of trospium chloride extended
release. Neurourol Urodyn 2010; 29: 551–4.
136 Subak LL, Wing R, West DS et al. Weight loss to
treat urinary incontinence in overweight and obese
women. N Engl J Med 2009; 360: 481–90.
137 Richter HE, Creasman JM, Myers DL et al. Urody-
namic characterization of obese women with uri-
nary incontinence undergoing a weight loss
program: the Program to Reduce Incontinence by
Diet and Exercise (PRIDE) trial. Int Urogynecol J
Pelvic Floor Dysfunct 2008; 19: 1653–8.
138 Franco I. Overactive bladder in children. Part 1:
Pathophysiology. J Urol 2007; 178: 761–8; discus-
sion 8.
139 De Wachter S, Wyndaele JJ. Impact of rectal dis-
tention on the results of evaluations of lower uri-
nary tract sensation. J Urol 2003; 169: 1392–4.
140 Ouslander JG. Management of overactive bladder.
N Engl J Med 2004; 350: 786–99.
141 Ng SC, Chen YC, Lin LY, Chen GD. Anorectal
dysfunction in women with urinary incontinence
or lower urinary tract symptoms. Int J Gynaecol
Obstet 2002; 77: 139–45.
142 Brown JS, Vittinghoff E, Wyman JF et al. Urinary
incontinence: does it increase risk for falls and
fractures? Study of Osteoporotic Fractures
Research Group. J Am Geriatr Soc 2000; 48: 721–5.
143 Brown JS, McGhan WF, Chokroverty S. Comor-
bidities associated with overactive bladder. Am J
Manag Care 2000; 6: 574–9.
144 Bo K, Talseth T, Vinsnes A. Randomized con-
trolled trial on the effect of pelvic ﬂoor muscle
training on quality of life and sexual problems in
genuine stress incontinent women. Acta Obstet
Gynecol Scand 2000; 79: 598–603.
145 Zahariou AG, Karamouti MV, Papaioannou PD.
Pelvic ﬂoor muscle training improves sexual func-
tion of women with stress urinary incontinence. Int
Urogynecol J Pelvic Floor Dysfunct 2008; 19: 401–6.
146 Koskimaki J, Hakama M, Huhtala H, Tammela
TL. Association of non-urological diseases with
lower urinary tract symptoms. Scand J Urol Neph-
rol 2001; 35: 377–81.
147 Koskimaki J, Hakama M, Huhtala H, Tammela
TL. Association of smoking with lower urinary
tract symptoms. J Urol 1998; 159: 1580–2.
148 Nuotio M, Jylha M, Koivisto AM, Tammela TL.
Association of smoking with urgency in older peo-
ple. Eur Urol 2001; 40: 206–12.
149 Bump RC, McClish DK. Cigarette smoking and
urinary incontinence in women. Am J Obstet
Gynecol 1992; 167: 1213–8.
150 Brownson RC, Chang JC, Davis JR. Occupation,
smoking, and alcohol in the epidemiology of blad-
der cancer. Am J Public Health 1987; 77: 1298–
300.
151 Baris D, Karagas MR, Verrill C et al. A case-con-
trol study of smoking and bladder cancer risk:
emergent patterns over time. J Natl Cancer Inst
2009; 101: 1553–61.
152 Bloom M. Primary Prevention Practices. Thousand
Oaks, CA: Sage Publications, Inc., 1996.
153 Herschorn S, Becker D, Miller E et al. Impact of a
health education intervention in overactive bladder
patients. Can J Urol 2004; 11: 2430–7.
154 Hines SH, Seng JS, Messer KL et al. Adherence to
a behavioral program to prevent incontinence.
West J Nurs Res 2007; 29: 36–56; discussion 7–64.
155 Miller YD, Brown WJ, Russell A, Chiarelli P. Uri-
nary incontinence across the lifespan. Neurourol
Urodyn 2003; 22: 550–7.
156 Landefeld CS, Bowers BJ, Feld AD et al. National
Institutes of Health State-of-the-Science Confer-
ence Statement: Prevention of Fecal and Urinary
Incontinence in Adults. Ann Intern Med 2008; 148:
449–58.
157 Suryanarayan D. A problem none want to discuss,
urinary incontinence. 2010 Available at: http://
www.dnaindia.com/mumbai/report_a-problem-
none-want-to-discuss-urinary-incontinence_1401-
752. (accessed 28 April 2011)
Paper received April 2011, accepted July 2011
1036 Consensus statement – a healthy bladder
ª 2011 Blackwell Publishing Ltd Int J Clin Pract, October 2011, 65, 10, 1026–1036